Abstract
No abstract available
Highlights
Vulval cancer is a relatively rare disease contributing to less than 5% of the gynaecological malignancies
When available, CT scan of the chest, abdomen and pelvis should be considered in patients with possible stage IB and beyond vulval cancer
When possible, multidisciplinary inputs should be obtained before planning surgery for vulval cancer
Summary
The purpose of this guideline is to describe the management of histologically confirmed vulval cancer and provide currently available best evidence to health care professionals to provide optimal care for these patients. Pre-operative staging, individualized treatment planning and appropriate adjuvant treatment and risk based follow up are corner stones in managing these patients. Patients should undergo speculum and per vaginal examination to assess for involvement of urethra, vagina and anus. Cervix should be inspected for possible synchronous lesions. Chest X ray should be performed in all patients to assess for lung metastasis. When available, CT scan of the chest, abdomen and pelvis should be considered in patients with possible stage IB and beyond vulval cancer. When possible, multidisciplinary inputs should be obtained before planning surgery for vulval cancer. It is recommended to involve clinicians with oncological background in the decisionmaking process
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
